RE:Givmeabrake...Thank you for sharing this info.
Review Type Committee Yes Votes FDA Approval Decisions (and predictive power %) Standard 45 (58.4%) 37 (82%) Priority 59 (76.6%) 53 (90%) Orphan 9 (60%) 9 (100%) Looks like we would be in pretty good shape following a AdCom positive decision. GLTAL